Table 2.

List of registered clinical trials expression ICIs CAR-T cells/T cells to treat cancer.

NCT number	CAR-T product	Target antigen	Disease	Clinical trial phase	Status	Location
NCT03179007	CTLA-4 and PD-1	MUC-1	Solid Tumor	1	Recruiting	Ningbo China
NCT03182816	CTLA-4 and PD-1	EGFR	NCLC	1	Recruiting	Ningbo China
NCT02862028	PD-1	EGFR	NCLC	1/2	Recruiting	Shanghai China
NCT03615313	PD-1	MSLN	Solid Tumor	1/2	Recruiting	Shanghai China
NCT03030001	PD-1	MSLN	Solid Tumor	1/2	Recruiting	Ningbo China